 LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 04, 2020 GLOBE NEWSWIRE -- uniQure N.V. NASDAQ: QURE, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that members of uniQures management team including Matt Kapusta, chief executive officer, Ricardo Dolmetsch, Ph.D., president of research development, and Maria Cantor, chief communications officer, with Chiara Russo, associate director of investor relations and communications, will participate in the following upcoming conferences in November: 